Update · October 8, 2026 INVARIANCE opens its launch partner program for AI agent providers. AI Agents
INVARIANCE
Independent execution authorization infrastructure for consequential AI.
AI agents can make decisions and initiate actions. INVARIANCE establishes an independent authorization boundary between those decisions and their execution.
If the check cannot run, the action does not.
For finance, insurance, healthcare and veterinary AI agent providers integrating independent execution authorization into their products.
Become a launch partnerThe system taking the action cannot be the system authorizing the action.
What INVARIANCE is
INVARIANCE decides, at an independent execution boundary, whether a specific action proposed by an AI system is authorized to execute. The system taking the action is never the system authorizing it.
Primary
Each consequential action is authorized or denied before it takes effect. If the check cannot run, the action does not.
Adjacent
A mistaken or compromised agent cannot turn its own intention into a real-world consequence.
Distinct
Governance establishes the rules. INVARIANCE independently authorizes execution against them.
What is execution authorization? How it differs from adjacent controls
source: VETPASS operating records · USPTO filing receipts · certification registers
Authorization infrastructure · the execution boundary
Illustrative architecture. Independent boundary verification takes place at release. Candidate · enter · policy · authorize · permit · execute · record · prove · no permit, no execution; denial is also evidence
Illustrative product representation
Candidate action
Example · action-bound authorization
authorize · policy FIN-07 · gate open
Company
INVARIANCE was founded by Damian Kissane, drawing on operating experience across three heavily regulated sectors: healthcare, financial services and insurance. In each, automated decisions carry immediate and sometimes irreversible consequences. The central question is not whether a system can produce a recommendation, but whether that recommendation is authorized to act.
Building production clinical AI at VETPASS exposed a consistent structural gap. Models produced increasingly capable outputs, yet no independent layer decided whether those outputs were allowed to take effect. INVARIANCE is that layer.
Inquiries from AI agent providers, enterprises, partners and investors go to the contact page.
Damian Kissane
Founder and CEO
Launch partner program now open for AI agent providers.
Become a launch partner